BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29780264)

  • 1. Methylation and Gene Expression of
    Jedi M; Young GP; Pedersen SK; Symonds EL
    Clin Med Insights Oncol; 2018; 12():1179554918775064. PubMed ID: 29780264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
    Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
    Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
    Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
    Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
    Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
    PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
    Pedersen SK; Symonds EL; Roy AC; Cornthwaite KJ; LaPointe LC; Young GP
    Cancer Med; 2023 Jan; 12(2):1319-1329. PubMed ID: 35822405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
    Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
    Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer.
    Young GP; Pedersen SK; Mansfield S; Murray DH; Baker RT; Rabbitt P; Byrne S; Bambacas L; Hollington P; Symonds EL
    Cancer Med; 2016 Oct; 5(10):2763-2772. PubMed ID: 27726312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
    Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
    Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
    Symonds EL; Pedersen SK; Baker RT; Murray DH; Gaur S; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Young GP
    Clin Transl Gastroenterol; 2016 Jan; 7(1):e137. PubMed ID: 26765125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
    Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
    BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1.
    Symonds EL; Pedersen SK; Yeo B; Al Naji H; Byrne SE; Roy A; Young GP
    Mol Oncol; 2022 May; 16(10):2031-2041. PubMed ID: 35000264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variables Associated with Detection of Methylated
    Saluja H; Young GP; Kholmurodova F; Symonds EL
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):774-781. PubMed ID: 33500319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer.
    Xu K; Yu AR; Pan SB; He J
    World J Gastroenterol; 2023 Sep; 29(36):5240-5253. PubMed ID: 37901447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer.
    Xie F; Xiang X; Huang Q; Ran P; Yuan Y; Li Q; Qi G; Guo X; Xiao C; Zheng S
    Oncotarget; 2017 Apr; 8(14):23628-23637. PubMed ID: 28416735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA hypermethylated status and gene expression of
    Huang J; Tan ZR; Yu J; Li H; Lv QL; Shao YY; Zhou HH
    Onco Targets Ther; 2017; 10():4739-4751. PubMed ID: 29033587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.
    Al Naji H; Winter JM; Pedersen SK; Roy A; Byrne SE; Young GP; Symonds EL
    Biomark Insights; 2024; 19():11772719241232870. PubMed ID: 38426070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Circulating Tumor DNA for Methylated
    Musher BL; Melson JE; Amato G; Chan D; Hill M; Khan I; Kochuparambil ST; Lyons SE; Orsini J; Pedersen SK; Robb B; Saltzman J; Silinsky J; Gaur S; Tuck MK; LaPointe LC; Young GP
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2702-2709. PubMed ID: 32958500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.
    Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.